Stockreport

Molecular Partners Reports Highlights from Q4 2024 and Key Financials for Full Year 2024

Molecular Partners AG - American Depositary Shares  (MOLN) 
PDF DLL3 targeting Radio-DARPin MP0712 to enter first-in-human study in 2025, pending regulatory clearanceStrategic partnership with Orano Med on Radio-DARPins now expanded [Read more]